亚洲化物通过减轻炎症和增强突触功能来减轻阿尔茨海默病的病理
Sai Liu1,2, Long Chen1,2, Jinran Li1,2
1State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
International journal of molecular sciences
|August 12, 2023
概括
亚洲化物 (AS) 通过减少神经炎症和改善小鼠的认知功能,对阿尔茨海默病 (AD) 治疗有希望. 这种天然化合物可能为神经退行性疾病提供新的治疗途径.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 的特点是粉样β (Aβ) 斑块和神经纤维状结.
- 目前的AD治疗侧重于症状管理;需要针对神经炎症和突触修复的新型治疗策略.
研究的目的:
- 在阿尔茨海默氏病的小鼠模型中研究亚西胺 (AS) 的神经保护作用.
- 阐明AS在AD的潜在治疗益处背后的机制.
主要方法:
- 在活体中向Aβ-1-42诱导的AD小鼠注射亚西化物 (40mg/kg).
- 评估认知功能,神经炎症标志物,微质激活和p38 MAPK通路.
主要成果:
- 在AD小鼠中,亚洲胺治疗减轻了认知功能障碍.
- 通过抑制微质激活和促炎因素,AS减弱了神经炎症.
- AS可能通过抑制p38 MAPK通路并促进突触修复来改善认知障碍.
结论:
- 在AD小鼠模型中,Asiaticoside表现出神经保护作用.
- 通过减少神经炎症和增强突触功能,AS具有作为阿尔茨海默病治疗剂的潜力.
相关概念视频
Alzheimer's Disease: Treatment
215
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
215
Alzheimer's Disease: Overview
521
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
521
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
155
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
155
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
Role of Neurotransmitters in Memory
628
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
628
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
716
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
716


